STARTUP LEGAL21 Sept 2026
Distressed Software Firm Symplr to Get Injection From Private Equity Backers | Company Business News
Symplr Software's private equity backers, Clearlake and Charlesbank, will put in about $175 million of preferred equity to steady the troubled healthcare software company. They will also defer interest on new junior debt, while second-lien lenders like Ares lend $103.5 million more. Lenders who skip the exchange lose protections. If you hold similar distressed paper, review your exposure.
Key Statutory Highlights
- Clearlake Capital Group and Charlesbank Capital Partners agreed to inject around $175 million of preferred equity into Symplr Software.
- Second-lien lenders including Ares Capital Corp. plan to provide $103.5 million of fresh money as a first-out second-lien loan.
- Investors who do not join the exchange will see their debt fall to the bottom of the capital structure and lose covenant protections.
Actionable Advice for Taxpayers / Founders:If your business or investment portfolio includes distressed software debt, it may be worth asking your advisor to review those holdings carefully, since terms here changed for lenders who did not participate.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: